|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 April 2001, Vol. 97, No. 7, pp. 2045-2052
HEMATOPOIESIS
Human skin-derived mast cells can proliferate while retaining
their characteristic functional and protease phenotypes
Naotomo Kambe,
Michiyo Kambe,
Jarema P. Kochan, and
Lawrence B. Schwartz
From the Department of Internal Medicine, Division of
Rheumatology, Allergy and Immunology, Virginia Commonwealth University,
Richmond, Virginia, and the Department of Metabolic Diseases,
Hoffman-La Roche, Nutley, New Jersey.
Human mast cells in adult tissues have been thought to have
limited, if any, proliferative potential. The current study examined mast cells obtained from adult skin and cultured in serum-free medium
with recombinant human stem cell factor. During the first 4 weeks of
culture, the percentages of mast cells increased from 10 to almost 100. After 8 weeks, a 150-fold increase in the number of mast cells was
observed. When freshly dispersed mast cells were individually sorted
onto human fibroblast monolayers and cultured for 3 weeks, one or more
mast cells were detected in about two thirds of the wells, and in about
two thirds of these wells the surviving mast cells showed evidence of
proliferation, indicating most mast cells in skin can proliferate. Such
mast cells all expressed high surface levels of Kit and Fc RI, each of which were functional, indicating IgE was not required for Fc RI
expression on mast cells. Such mast cells also retained the
MCTC protease phenotype of mast cells that normally reside in the dermis. After 4 to 8 weeks of culture these mast cells degranulated in response to substance P and compound 48/80,
characteristics of skin-derived mast cells that persist outside
of the cutaneous microenvironment.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Zhao, G. Gomez, S.-H. Yu, J. J. Ryan, and L. B. Schwartz
TGF-{beta}1 Attenuates Mediator Release and De Novo Kit Expression by Human Skin Mast Cells through a Smad-Dependent Pathway
J. Immunol.,
November 15, 2008;
181(10):
7263 - 7272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Fukuoka, H.-Z. Xia, L. B. Sanchez-Munoz, A. L. Dellinger, L. Escribano, and L. B. Schwartz
Generation of Anaphylatoxins by Human {beta}-Tryptase from C3, C4, and C5
J. Immunol.,
May 1, 2008;
180(9):
6307 - 6316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gomez, S. Jogie-Brahim, M. Shima, and L. B. Schwartz
Omalizumab Reverses the Phenotypic and Functional Effects of IgE-Enhanced Fc{epsilon}RI on Human Skin Mast Cells
J. Immunol.,
July 15, 2007;
179(2):
1353 - 1361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tessier, C. Green, D. Padgett, W. Zhao, L. Schwartz, M. Hughes, and E. Hewlett
Contributions of Histamine, Prostanoids, and Neurokinins to Edema Elicited by Edema Toxin from Bacillus anthracis
Infect. Immun.,
April 1, 2007;
75(4):
1895 - 1903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhao, C. L. Kepley, P. A. Morel, L. M. Okumoto, Y. Fukuoka, and L. B. Schwartz
Fc{gamma}RIIa, Not Fc{gamma}RIIb, Is Constitutively and Functionally Expressed on Skin-Derived Human Mast Cells
J. Immunol.,
July 1, 2006;
177(1):
694 - 701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Schiemann, T. A. Grimm, J. Hoch, R. Gross, B. Lindner, F. Petersen, S. Bulfone-Paus, and E. Brandt
Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G
Blood,
March 15, 2006;
107(6):
2234 - 2242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhao, C. A. Oskeritzian, A. L. Pozez, and L. B. Schwartz
Cytokine Production by Skin-Derived Mast Cells: Endogenous Proteases Are Responsible for Degradation of Cytokines
J. Immunol.,
August 15, 2005;
175(4):
2635 - 2642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bagga, K. S. Price, D. A. Lin, D. S. Friend, K. F. Austen, and J. A. Boyce
Lysophosphatidic acid accelerates the development of human mast cells
Blood,
December 15, 2004;
104(13):
4080 - 4087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Oskeritzian, W. Zhao, A. L. Pozez, N. M. Cohen, M. Grimes, and L. B. Schwartz
Neutralizing Endogenous IL-6 Renders Mast Cells of the MCT Type from Lung, but Not the MCTC Type from Skin and Lung, Susceptible to Human Recombinant IL-4-Induced Apoptosis
J. Immunol.,
January 1, 2004;
172(1):
593 - 600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kumamoto, D. Shalhevet, H. Matsue, M. E. Mummert, B. R. Ward, J. V. Jester, and A. Takashima
Hair follicles serve as local reservoirs of skin mast cell precursors
Blood,
September 1, 2003;
102(5):
1654 - 1660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Schwartz, H.-K. Min, S. Ren, H.-Z. Xia, J. Hu, W. Zhao, G. Moxley, and Y. Fukuoka
Tryptase Precursors Are Preferentially and Spontaneously Released, Whereas Mature Tryptase Is Retained by HMC-1 Cells, Mono-Mac-6 Cells, and Human Skin-Derived Mast Cells
J. Immunol.,
June 1, 2003;
170(11):
5667 - 5673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bradding, Y. Okayama, N. Kambe, and H. Saito
Ion channel gene expression in human lung, skin, and cord blood-derived mast cells
J. Leukoc. Biol.,
May 1, 2003;
73(5):
614 - 620.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|